The OIG has released a report on "Medicare Prescription Drug Sponsors’ Training to Prevent Fraud, Waste, and Abuse." CMS requires all Medicare Part D prescription drug plan sponsors to have compliance plans that include effective annual training and education for network pharmacies to prevent fraud, waste, and abuse. Based on a survey of all Part D sponsors and a random sample of 528 pharmacies, the OIG found that nearly all Part D network pharmacies received such training in 2009, but not all sponsors documented the training. Furthermore, over one-third of the training materials reviewed failed to include information on the Health Insurance Portability and Accountability Act, and more than half of the materials were developed by pharmacies’ corporate offices, contrary to CMS guidance. The OIG also reports that some sponsors did not assess or were unable to determine the extent to which training was effective in preventing fraud, waste, and abuse. The OIG recommends that CMS: reiterate to sponsors their fraud training responsibilities; monitor to determine sponsors’ compliance with the training requirements; and ensure that such training is effective in preventing, detecting, and responding to fraud, waste, and abuse. CMS concurred with the recommendations.